All of these findings suggest an interesting function of SLC35D3 in obesity, and low SLC35D3 expression in adipose tissues in obesity might be a potential therapeutic target (Fig. 9). This evidence concerns the gene SLC35D3 and obesity due to melanocortin 4 receptor deficiency.